Effectiveness of mandibular advancement devices in obstructive sleep apnea therapy for East Asian patients: a systematic review and meta-analysis.

IF 2.9 3区 医学 Q1 CLINICAL NEUROLOGY Journal of Clinical Sleep Medicine Pub Date : 2025-07-01 DOI:10.5664/jcsm.11626
Chee Weng Yong, Bernadette Quah, Juliana Tereza Colpani, Frank Kong Fei Lee, Eugene Eu-Min Loh, Raymond Chung Wen Wong
{"title":"Effectiveness of mandibular advancement devices in obstructive sleep apnea therapy for East Asian patients: a systematic review and meta-analysis.","authors":"Chee Weng Yong, Bernadette Quah, Juliana Tereza Colpani, Frank Kong Fei Lee, Eugene Eu-Min Loh, Raymond Chung Wen Wong","doi":"10.5664/jcsm.11626","DOIUrl":null,"url":null,"abstract":"<p><p>Prior studies have shown that a mandibular advancement device (MAD) is an effective nonsurgical treatment for obstructive sleep apnea. Most studies were performed in primarily White populations. However, East Asians have restrictive craniofacial features, such as a reduced cranial base, maxilla, and retropalatal space, which may affect their response to treatment. The objective of this study was to systematically review the use of MAD in East Asian patients and determine the effectiveness of MAD in this population. The PubMed, Embase, Scopus, CINAHL, Web of Science, and Cochrane Library databases were searched up to January 15, 2024. Studies that investigated the effects of MAD on the apnea-hypopnea index, oxygen saturation, blood pressure, and Epworth Sleepiness Scale score specifically for East Asian patients were included. Preferred Reporting Items for Systematic Reviews and Meta-analyses guidelines were followed for data extraction. Twelve studies with 382 patients were included. The pooled mean reduction in apnea-hypopnea index was 19.1 (95% confidence interval [CI] = -23.9; -14.3, <i>I</i><sup>2</sup> = 91%). The improvements in the minimal and mean oxygen saturation were 6.0% (95% CI = 4.4; 7.5, <i>I</i><sup>2</sup> = 28%) and 1.2% (95% CI = -0.2; 2.6, <i>I</i><sup>2</sup> = 92%), respectively. Oxygen desaturation index was also reduced by 13.6 (3 studies, 95% CI = 23.9; -3.3, <i>I</i><sup>2</sup> = 92%). Systolic and diastolic pressure changes were modest at -4.4 (9% CI = -11.3; 2.4, <i>I</i><sup>2</sup> = 88%) and -3.3 (95% CI = -6.3; -0.3, <i>I</i><sup>2</sup> = 55%), respectively. Epworth Sleepiness Scale score had a reduction of 2.0 (95% CI = -3.3; -0.7, <i>I</i><sup>2</sup> = 66%). MAD is an effective device for the management of East Asian patients with obstructive sleep apnea. Although treatment success is expected in most patients, complete resolution is unlikely.</p><p><strong>Citation: </strong>Yong CW, Quah B, Colpani JT, Lee FKF, Loh EE-M, Wong RCW. Effectiveness of mandibular advancement devices in obstructive sleep apnea therapy for East Asian patients: a systematic review and meta-analysis. <i>J Clin Sleep Med.</i> 2025;21(7):1261-1271.</p>","PeriodicalId":50233,"journal":{"name":"Journal of Clinical Sleep Medicine","volume":" ","pages":"1261-1271"},"PeriodicalIF":2.9000,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12225283/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Clinical Sleep Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.5664/jcsm.11626","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Prior studies have shown that a mandibular advancement device (MAD) is an effective nonsurgical treatment for obstructive sleep apnea. Most studies were performed in primarily White populations. However, East Asians have restrictive craniofacial features, such as a reduced cranial base, maxilla, and retropalatal space, which may affect their response to treatment. The objective of this study was to systematically review the use of MAD in East Asian patients and determine the effectiveness of MAD in this population. The PubMed, Embase, Scopus, CINAHL, Web of Science, and Cochrane Library databases were searched up to January 15, 2024. Studies that investigated the effects of MAD on the apnea-hypopnea index, oxygen saturation, blood pressure, and Epworth Sleepiness Scale score specifically for East Asian patients were included. Preferred Reporting Items for Systematic Reviews and Meta-analyses guidelines were followed for data extraction. Twelve studies with 382 patients were included. The pooled mean reduction in apnea-hypopnea index was 19.1 (95% confidence interval [CI] = -23.9; -14.3, I2 = 91%). The improvements in the minimal and mean oxygen saturation were 6.0% (95% CI = 4.4; 7.5, I2 = 28%) and 1.2% (95% CI = -0.2; 2.6, I2 = 92%), respectively. Oxygen desaturation index was also reduced by 13.6 (3 studies, 95% CI = 23.9; -3.3, I2 = 92%). Systolic and diastolic pressure changes were modest at -4.4 (9% CI = -11.3; 2.4, I2 = 88%) and -3.3 (95% CI = -6.3; -0.3, I2 = 55%), respectively. Epworth Sleepiness Scale score had a reduction of 2.0 (95% CI = -3.3; -0.7, I2 = 66%). MAD is an effective device for the management of East Asian patients with obstructive sleep apnea. Although treatment success is expected in most patients, complete resolution is unlikely.

Citation: Yong CW, Quah B, Colpani JT, Lee FKF, Loh EE-M, Wong RCW. Effectiveness of mandibular advancement devices in obstructive sleep apnea therapy for East Asian patients: a systematic review and meta-analysis. J Clin Sleep Med. 2025;21(7):1261-1271.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
下颌推进装置在东亚患者阻塞性睡眠呼吸暂停治疗中的有效性:一项系统回顾和荟萃分析。
先前的研究表明,下颌推进装置(MAD)是一种有效的非手术治疗阻塞性睡眠呼吸暂停(OSA)。大多数研究主要是在白人人群中进行的。然而,东亚人有限制性颅面特征,如颅底、上颌骨和腭后间隙缩小,这可能会影响他们对治疗的反应。本研究的目的是系统回顾东亚患者使用MAD的情况,并确定MAD在该人群中的有效性。检索截止到2024年1月15日的PubMed、Embase、Scopus、CINAHL、Web of Science和Cochrane Library数据库。研究了MAD对呼吸暂停低通气指数(AHI)、血氧饱和度、血压和Epworth嗜睡量表(ESS)评分的影响,特别是对东亚患者。数据提取遵循PRISMA指南。纳入了12项研究,共382例患者。合并后AHI平均降低19.1 (95% CI -23.9;-14.3,I2 = 91%)。最小和平均血氧饱和度的改善分别为6.0% (95% CI 4.4, 7.5,I2 = 28%)和1.2% (95% CI -0.2, 2.6),I2 = 92%)。氧去饱和指数也降低了13.6(3项研究,95% CI 23.9;-3.3,I2 = 92%)。收缩压和舒张压变化适中,分别为-4.4 (9% CI = -11.3;2.4,I2 = 88%)和-3.3 (95% CI = -6.3;-0.3,I2 = 55%)。ESS评分降低2.0 (95% CI= -3.3;-0.7,I2 =66%)。MAD是治疗东亚OSA患者的有效手段。虽然大多数患者预期治疗成功,但完全治愈是不可能的。(253字)。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
6.20
自引率
7.00%
发文量
321
审稿时长
1 months
期刊介绍: Journal of Clinical Sleep Medicine focuses on clinical sleep medicine. Its emphasis is publication of papers with direct applicability and/or relevance to the clinical practice of sleep medicine. This includes clinical trials, clinical reviews, clinical commentary and debate, medical economic/practice perspectives, case series and novel/interesting case reports. In addition, the journal will publish proceedings from conferences, workshops and symposia sponsored by the American Academy of Sleep Medicine or other organizations related to improving the practice of sleep medicine.
期刊最新文献
Safety principles of lowering inspiratory pressure. Restless legs syndrome, heart diseases, iron therapy and inflammation: a causal relationship. Correction: Does the use of continuous positive airway pressure devices pose a risk of microplastic exposure to the upper airway? A pilot study. Automatic activation of neurostimulation for central sleep apnea results in high nightly usage. Who's counting? Discrepancies between caregiver-reported, youth-reported, and Fitbit sleep in the ABCD study.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1